← 返回

Pleckstrin-2 通过激活胃癌中的 MT1-MMP-MICA 信号轴促进肿瘤免疫逃逸 NK 细胞

英文原题:Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.

查看英文原题

Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.

PubMed 2023/08/15(内容时间) Cancer Lett Q1 · IF 11.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

免疫逃逸是肿瘤免疫治疗中的主要挑战。Pleckstrin-2(PLEK2)在肿瘤进展中发挥关键作用,但其在胃癌(GC)免疫逃逸中的作用尚未明确。采用RNA测序技术探索对自然杀伤(NK)细胞抗肿瘤作用耐药的GC细胞系中的差异表达基因。通过流式细胞术(FCM)检测细胞凋亡及IFN-γ和TNF-α的表达。通过Western blotting和免疫组化(IHC)检测PLEK2表达。PLEK2在对NK细胞抗肿瘤作用耐药的MGC803R细胞中表达上调。PLEK2敲除增加了GC细胞对NK细胞杀伤的敏感性。在体外和体内实验中,PLEK2表达与MICA呈负相关,与MT1-MMP表达呈正相关。PLEK2通过PI3K-AKT通路促进Sp1磷酸化,从而上调MT1-MMP表达,最终导致MICA脱落。在小鼠异种移植模型中,PLEK2敲除抑制了GC细胞的腹腔内转移并促进了NK细胞浸润。

总之,PLEK2通过促进MICA脱落抑制NK细胞免疫监视,可作为GC的潜在治疗靶点。

展开英文摘要原文

Immune escape is a major challenge in tumour immunotherapy. Pleckstrin-2(PLEK2) plays a critical role in tumour progression, but its role in immune escape in gastric cancer (GC) remains uncharacterized. RNA sequencing was used to explore the differentially expressed genes in a GC cell line that was resistant to the antitumor effect of Natural killer (NK) cells. Apoptosis and the expression of IFN-γ and TNF-α were detected by flow cytometry (FCM). PLEK2 expression was examined by Western blotting and immunohistochemistry (IHC). PLEK2 was upregulated in MGC803R cells that were resistant to the antitumor effect of NK cells.

PLEK2 knockout increased the sensitivity of GC cells to NK cell killing. PLEK2 expression was negatively correlated with MICA and positively correlated with MT1-MMP expression both in vitro and in vivo. PLEK2 promoted Sp1 phosphorylation through the PI3K-AKT pathway, thereby upregulating MT1-MMP expression, which ultimately led to MICA shedding.

In mouse xenograft models, PLEK2 knockout inhibited intraperitoneal metastasis of GC cells and promoted NK cell infiltration. In summary, PLEK2 suppressed NK cell immune surveillance by promoting MICA shedding, which serves as a potential therapeutic target for GC.

论文信息

作者
Mao D、Zhou Z、Chen H、Liu X、Li D、Chen X、He Y、Liu M
第一作者单位
Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen, 518107, Guangdong, China; Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen, 518107, Guangdong, China.China
通讯作者单位
Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen, 518107, Guangdong, China; Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen, 518107, Guangdong, China. Electronic address: zhchangh@mail.sysu.edu.cn.China
文献类型
非美国政府资助研究
期刊
Cancer letters2023 Sep 28
原文标识
PubMed 37591356 · DOI 10.1016/j.canlet.2023.216351